Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user?s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.
Barbiturates become dangerous when combined with other depressants such as alcohol. There is a high risk of dependency from regular use of barbiturate drugs. This can be a physical dependency, psychological dependency, or both. The amount required for overdose varies from person to person.
North America is expected to account for the largest share of the global market from 2018 to 2025, due to highest percentage of insomnia affected patients.
In 2019, the market size of Barbiturate Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Barbiturate Drugs.
This report studies the global market size of Barbiturate Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Barbiturate Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Valeant Pharmaceuticals
Oak Pharmaceuticals
Meda pharmaceuticals
Market Segment by Product Type
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Barbiturate Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Barbiturate Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Barbiturate Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user?s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.
Barbiturates become dangerous when combined with other depressants such as alcohol. There is a high risk of dependency from regular use of barbiturate drugs. This can be a physical dependency, psychological dependency, or both. The amount required for overdose varies from person to person.
North America is expected to account for the largest share of the global market from 2018 to 2025, due to highest percentage of insomnia affected patients.
In 2019, the market size of Barbiturate Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Barbiturate Drugs.
This report studies the global market size of Barbiturate Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Barbiturate Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Valeant Pharmaceuticals
Oak Pharmaceuticals
Meda pharmaceuticals
Market Segment by Product Type
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Barbiturate Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Barbiturate Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Barbiturate Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Barbiturate Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Ultra-Short Acting Barbiturate
1.3.3 Short-Acting Barbiturate
1.3.4 Long-Acting Barbiturate
1.3.5 Combination Drugs
1.4 Market Segment by Application
1.4.1 Global Barbiturate Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Barbiturate Drugs Market Size
2.1.1 Global Barbiturate Drugs Revenue 2014-2025
2.1.2 Global Barbiturate Drugs Sales 2014-2025
2.2 Barbiturate Drugs Growth Rate by Regions
2.2.1 Global Barbiturate Drugs Sales by Regions 2014-2019
2.2.2 Global Barbiturate Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Barbiturate Drugs Sales by Manufacturers
3.1.1 Barbiturate Drugs Sales by Manufacturers 2014-2019
3.1.2 Barbiturate Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Barbiturate Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Barbiturate Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Barbiturate Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Barbiturate Drugs Price by Manufacturers
3.4 Key Manufacturers Barbiturate Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Barbiturate Drugs Market
3.6 Key Manufacturers Barbiturate Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Ultra-Short Acting Barbiturate Sales and Revenue (2014-2019)
4.1.2 Short-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.3 Long-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.4 Combination Drugs Sales and Revenue (2014-2019)
4.2 Global Barbiturate Drugs Sales Market Share by Type
4.3 Global Barbiturate Drugs Revenue Market Share by Type
4.4 Barbiturate Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Barbiturate Drugs Sales by Application
6 United States
6.1 United States Barbiturate Drugs Breakdown Data by Company
6.2 United States Barbiturate Drugs Breakdown Data by Type
6.3 United States Barbiturate Drugs Breakdown Data by Application
7 European Union
7.1 European Union Barbiturate Drugs Breakdown Data by Company
7.2 European Union Barbiturate Drugs Breakdown Data by Type
7.3 European Union Barbiturate Drugs Breakdown Data by Application
8 China
8.1 China Barbiturate Drugs Breakdown Data by Company
8.2 China Barbiturate Drugs Breakdown Data by Type
8.3 China Barbiturate Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Barbiturate Drugs Breakdown Data by Company
9.2 Rest of World Barbiturate Drugs Breakdown Data by Type
9.3 Rest of World Barbiturate Drugs Breakdown Data by Application
9.4 Rest of World Barbiturate Drugs Breakdown Data by Countries
9.4.1 Rest of World Barbiturate Drugs Sales by Countries
9.4.2 Rest of World Barbiturate Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.1.4 Barbiturate Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.2.4 Barbiturate Drugs Product Introduction
10.2.5 Merck Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.3.4 Barbiturate Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Mylan
10.4.1 Mylan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.4.4 Barbiturate Drugs Product Introduction
10.4.5 Mylan Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.5.4 Barbiturate Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.6.4 Barbiturate Drugs Product Introduction
10.6.5 Teva Pharmaceutical Recent Development
10.7 Sumitomo Dainippon Pharma
10.7.1 Sumitomo Dainippon Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.7.4 Barbiturate Drugs Product Introduction
10.7.5 Sumitomo Dainippon Pharma Recent Development
10.8 Valeant Pharmaceuticals
10.8.1 Valeant Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.8.4 Barbiturate Drugs Product Introduction
10.8.5 Valeant Pharmaceuticals Recent Development
10.9 Oak Pharmaceuticals
10.9.1 Oak Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.9.4 Barbiturate Drugs Product Introduction
10.9.5 Oak Pharmaceuticals Recent Development
10.10 Meda pharmaceuticals
10.10.1 Meda pharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.10.4 Barbiturate Drugs Product Introduction
10.10.5 Meda pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Barbiturate Drugs Sales Channels
11.2.2 Barbiturate Drugs Distributors
11.3 Barbiturate Drugs Customers
12 Market Forecast
12.1 Global Barbiturate Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Barbiturate Drugs Sales Forecast by Type
12.3 Global Barbiturate Drugs Sales Forecast by Application
12.4 Barbiturate Drugs Forecast by Regions
12.4.1 Global Barbiturate Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Barbiturate Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Barbiturate Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Ultra-Short Acting Barbiturate
1.3.3 Short-Acting Barbiturate
1.3.4 Long-Acting Barbiturate
1.3.5 Combination Drugs
1.4 Market Segment by Application
1.4.1 Global Barbiturate Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Barbiturate Drugs Market Size
2.1.1 Global Barbiturate Drugs Revenue 2014-2025
2.1.2 Global Barbiturate Drugs Sales 2014-2025
2.2 Barbiturate Drugs Growth Rate by Regions
2.2.1 Global Barbiturate Drugs Sales by Regions 2014-2019
2.2.2 Global Barbiturate Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Barbiturate Drugs Sales by Manufacturers
3.1.1 Barbiturate Drugs Sales by Manufacturers 2014-2019
3.1.2 Barbiturate Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Barbiturate Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Barbiturate Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Barbiturate Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Barbiturate Drugs Price by Manufacturers
3.4 Key Manufacturers Barbiturate Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Barbiturate Drugs Market
3.6 Key Manufacturers Barbiturate Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Ultra-Short Acting Barbiturate Sales and Revenue (2014-2019)
4.1.2 Short-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.3 Long-Acting Barbiturate Sales and Revenue (2014-2019)
4.1.4 Combination Drugs Sales and Revenue (2014-2019)
4.2 Global Barbiturate Drugs Sales Market Share by Type
4.3 Global Barbiturate Drugs Revenue Market Share by Type
4.4 Barbiturate Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Barbiturate Drugs Sales by Application
6 United States
6.1 United States Barbiturate Drugs Breakdown Data by Company
6.2 United States Barbiturate Drugs Breakdown Data by Type
6.3 United States Barbiturate Drugs Breakdown Data by Application
7 European Union
7.1 European Union Barbiturate Drugs Breakdown Data by Company
7.2 European Union Barbiturate Drugs Breakdown Data by Type
7.3 European Union Barbiturate Drugs Breakdown Data by Application
8 China
8.1 China Barbiturate Drugs Breakdown Data by Company
8.2 China Barbiturate Drugs Breakdown Data by Type
8.3 China Barbiturate Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Barbiturate Drugs Breakdown Data by Company
9.2 Rest of World Barbiturate Drugs Breakdown Data by Type
9.3 Rest of World Barbiturate Drugs Breakdown Data by Application
9.4 Rest of World Barbiturate Drugs Breakdown Data by Countries
9.4.1 Rest of World Barbiturate Drugs Sales by Countries
9.4.2 Rest of World Barbiturate Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.1.4 Barbiturate Drugs Product Introduction
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.2.4 Barbiturate Drugs Product Introduction
10.2.5 Merck Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.3.4 Barbiturate Drugs Product Introduction
10.3.5 Eli Lilly Recent Development
10.4 Mylan
10.4.1 Mylan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.4.4 Barbiturate Drugs Product Introduction
10.4.5 Mylan Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.5.4 Barbiturate Drugs Product Introduction
10.5.5 Sanofi Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.6.4 Barbiturate Drugs Product Introduction
10.6.5 Teva Pharmaceutical Recent Development
10.7 Sumitomo Dainippon Pharma
10.7.1 Sumitomo Dainippon Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.7.4 Barbiturate Drugs Product Introduction
10.7.5 Sumitomo Dainippon Pharma Recent Development
10.8 Valeant Pharmaceuticals
10.8.1 Valeant Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.8.4 Barbiturate Drugs Product Introduction
10.8.5 Valeant Pharmaceuticals Recent Development
10.9 Oak Pharmaceuticals
10.9.1 Oak Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.9.4 Barbiturate Drugs Product Introduction
10.9.5 Oak Pharmaceuticals Recent Development
10.10 Meda pharmaceuticals
10.10.1 Meda pharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Barbiturate Drugs
10.10.4 Barbiturate Drugs Product Introduction
10.10.5 Meda pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Barbiturate Drugs Sales Channels
11.2.2 Barbiturate Drugs Distributors
11.3 Barbiturate Drugs Customers
12 Market Forecast
12.1 Global Barbiturate Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Barbiturate Drugs Sales Forecast by Type
12.3 Global Barbiturate Drugs Sales Forecast by Application
12.4 Barbiturate Drugs Forecast by Regions
12.4.1 Global Barbiturate Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Barbiturate Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
